Maintenance chemotherapy in biliary tract tumours in the era of immuno-chemotherapy

Maintenance chemotherapy in biliary tract tumours in the era of immuno-chemotherapy

Biliary tract tumours (BTCs) are malignancies with a poor prognosis. Regarding first-line therapy options, cisplatin and gemcitabine (CisGem) alone has been the standard therapy option for more than a decade. This has changed recently, due to the incorporation of immunotherapy into this combo, with...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Lamarca, J. Adeva, I. Ales Díaz, R. Alvarez Gallego, A.J. Muñoz Martín, T. Macarulla Mercade
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:ESMO Gastrointestinal Oncology
Subjects:
biliary tract tumours
chemotherapy
duration
maintenance
Online Access:http://www.sciencedirect.com/science/article/pii/S2949819824000773
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items